Hyundai Pharmaceutical's hair loss treatment 20,000 bottles are recalled

Reporter Kim Jisun / approved : 2023-07-03 05:10:44
  • -
  • +
  • 인쇄

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Hyundai Pharmaceutical is collecting the drug after it was reported that the hair loss treatment drug on sale is mixed with dementia treatment.

It is known that the products subject to recall are mixed with dementia treatments. This was revealed through a pharmacist's report. About 20,000 bottles of recalled products are said to have been produced.

The Ministry of Food and Drug Safety and Hyundai Pharmaceutical are announcing the recall of the product in question through the company's website. Separately, the Ministry of Food and Drug Safety is investigating how the incident occurred and whether consumers took it.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

[Exclusive] Samsung Electronics Passes NVIDIA’s HBM3E 12-High Qualification Test, Secures Supply Deal2025.09.19
Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사